Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy
- PMID: 36651610
- DOI: 10.2214/AJR.23.29011
Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy
Comment on
-
Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study.JAMA Oncol. 2022 Nov 10;9(1):88-94. doi: 10.1001/jamaoncol.2022.5252. Online ahead of print. JAMA Oncol. 2022. PMID: 36355382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
